nad has been researched along with marizomib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnihotri, S; Brenner, C; Casillo, SM; Dange, R; Gatesman, TA; Golbourn, BJ; Halbert, ME; Jane, EP; Michealraj, A; Miller, TA; Mohanakrishnan, D; Mullett, SJ; Obodo, U; Pollack, IF; Premkumar, DR; Reslink, MC; Wendell, SG | 1 |
1 other study(ies) available for nad and marizomib
| Article | Year |
|---|---|
Targeting mitochondrial energetics reverses panobinostat- and marizomib-induced resistance in pediatric and adult high-grade gliomas.
Topics: Adult; Cell Line, Tumor; Child; Glioma; Humans; Mitochondria; NAD; Panobinostat; Proteasome Inhibitors | 2023 |